At present, the blood transfusion process of most hospitals in China is not standardized. The surgery department does not transfuse blood according to the provisions of the technical specifications of clinical blood transfusion and other relevant documents. The clinical blood transfusion management committee did not play its due role. Hospitals have rules and regulations for blood transfusion, but lack training. These problems lead to blood transfusion treatment is invalid, or even “mistyped blood” accident to happen from time to time and responsibility is difficult to define, these problems endanger the patient lives, also is the main reason that lead to medical disputes.
In order to solve this problem, the hospital by introducing RFID technology innovation, to include every bag of blood in IOT architecture, realize the automation of blood storage to the patients with regulation, overcome the dependency of manual operation, will lead to the error of “human” factor to minimum. At the same time, the whole process of blood quality can be traced back to solve the problem of blood quality management. In addition, the handover of blood samples is also completed through RFID tags and intelligent reading devices, which can quickly complete the handover of blood samples, reduce the handover workload and time, and reduce the error rate.
At present, HongCheng innovation is carrying out empirical research cooperation with Beijing hospital to verify the efficiency and reliability of this solution in clinical blood transfusion management. This solution will be promoted in several famous hospitals.
The report predicts that between 2017 and 2023, the global RFID blood monitoring system will grow at a rate of 21% to 22%. Research on the RFID blood monitoring system market covers analysis in North America, Europe, Asia-Pacific and other parts of the world. North America dominates the global market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period.